Kalyan C. Nannuru

<i>ACVR1</i> ^<i>R206H</i> receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A

Sarah Hatsell, Vincent Idone, Dana M. Alessi Wolken et al. · Science Translational Medicine · 2015 · 433 citations · Full text

Activin Family, Sclerostin, Cell Death +19

Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis

Seema Singh, Anguraj Sadanandam, Kalyan C. Nannuru et al. · Clinical Cancer Research · 2009 · 159 citations · Full text

Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone Interface

Kalyan C. Nannuru, Mitsuru Futakuchi, Michelle L. Varney et al. · Cancer Research · 2010 · 123 citations · Full text

Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis

Bhawna Sharma, Dhananjay M. Nawandar, Kalyan C. Nannuru et al. · Molecular Cancer Therapeutics · 2013 · 115 citations · Full text

Cathepsin G Enhances Mammary Tumor–Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-κB Ligand

Thomas J. Wilson, Kalyan C. Nannuru, Mitsuru Futakuchi et al. · Cancer Research · 2008 · 90 citations